CV: Arrhythmias Flashcards
If ectopic beats are spontaneous and the patient has a normal heart, treatment is rarely required and reassurance to the patient will often suffice. If they are particularly troublesome, what treatment should be used?
If ectopic beats are spontaneous and the patient has a normal heart, treatment is rarely required and reassurance to the patient will often suffice. If they are particularly troublesome, beta-blockers are sometimes effective and may be safer than other suppressant drugs.
Atrial fibrillation can be managed by either controlling the ventricular rate (‘r______ control’) or by attempting to restore and maintain sinus rhythm (‘______ control’).
Atrial fibrillation can be managed by either controlling the ventricular rate (‘rate control’) or by attempting to restore and maintain sinus rhythm (‘rhythm control’).
All patients with life-threatening haemodynamic instability caused by new-onset atrial fibrillation should undergo what without delaying to achieve anticoagulation?
All patients with life-threatening haemodynamic instability caused by new-onset atrial fibrillation should undergo emergency electrical cardioversion without delaying to achieve anticoagulation.
In patients presenting acutely but without life-threatening haemodynamic instability, rate or rhythm control can be offered if the onset of arrhythmia is less than __ hours; _____ control is preferred if onset is more than __ hours or uncertain.
In patients presenting acutely but without life-threatening haemodynamic instability, rate or rhythm control can be offered if the onset of arrhythmia is less than 48 hours; rate control is preferred if onset is more than 48 hours or uncertain.
If pharmacological cardioversion has been agreed, intravenous _____________, or alternatively _______ acetate, can be used (_______ hydrochloride is preferred if there is structural heart disease). If urgent rate control is required, a beta-blocker or verapamil hydrochloride can be given intravenously.
If pharmacological cardioversion has been agreed, intravenous amiodarone hydrochloride, or alternatively flecainide acetate, can be used (amiodarone hydrochloride is preferred if there is structural heart disease). If urgent rate control is required, a beta-blocker or verapamil hydrochloride can be given intravenously.
If pharmacological cardioversion has been agreed, intravenous amiodarone hydrochloride, or alternatively flecainide acetate, can be used (amiodarone hydrochloride is preferred if there is structural heart disease).
If urgent rate control is required, a ________ or ___________can be given intravenously.
If pharmacological cardioversion has been agreed, intravenous amiodarone hydrochloride, or alternatively flecainide acetate, can be used (amiodarone hydrochloride is preferred if there is structural heart disease). If urgent rate control is required, a beta-blocker or verapamil hydrochloride can be given intravenously.
If atrial fibrillation has been present for more than 48 hours, _________ cardioversion is preferred and should not be attempted until the patient has been fully anticoagulated for at least 3 weeks; if this is not possible, parenteral anticoagulation should be commenced.
If atrial fibrillation has been present for more than 48 hours, electrical cardioversion is preferred and should not be attempted until the patient has been fully anticoagulated for at least 3 weeks; if this is not possible, parenteral anticoagulation should be commenced, an
What is the preferred first-line drug treatment strategy for atrial fibrillation except in patients with new-onset AF, heart failure secondary to AF AF suitable for ablation therapy or with a rerversible cause?
Rate control is the preferred first-line drug treatment strategy for atrial fibrillation except in patients with new-onset atrial fibrillation, heart failure secondary to atrial fibrillation, atrial flutter suitable for an ablation strategy, atrial fibrillation with a reversible cause, or if rhythm control is more suitable based on clinical judgement.
Ventricular rate can be controlled with what? (2)
- Standard beta-blocker (NOT sotalol)
2. A rate-limiting CCB such as diltiazem or verapamil monotherapy.
Digoxin should be used only in what AF patients?
Digoxin is only effective at controlling the ventricular rate at rest, and should only be used as monotherapy predominantly in patients who are sedentary with non-paroxysmal atrial fibrillation.
If rate control monotherapy of AF fails what can be done?
When a single drug fails to adequately control the ventricular rate, a combination of two drugs including a beta-blocker, digoxin, or diltiazem hydrochloride can be used.
If rate control dual therapy of AF fails what can be done?
If symptoms are not controlled with a combination of two drugs, a rhythm-control strategy should be considered. If ventricular function is diminished, the combination of a beta-blocker (that is licensed for use in heart failure) and digoxin is preferred. Digoxin is also used when atrial fibrillation is accompanied by congestive heart failure.
In AF, if ventricular function is diminished, the combination of a beta-blocker licensed for use in heart failure and what is preffered?
If symptoms are not controlled with a combination of two drugs, a rhythm-control strategy should be considered. If ventricular function is diminished, the combination of a beta-blocker (that is licensed for use in heart failure) and digoxin is preferred. Digoxin is also used when atrial fibrillation is accompanied by congestive heart failure.
If drug treatment is required to maintain sinus rhythm (rhythm control) post-cardioversion, what should be used?
If drug treatment is required to maintain sinus rhythm (‘rhythm control’) post-cardioversion, a standard beta-blocker is used. If a standard beta-blocker is not appropriate or is ineffective, consider an oral anti-arrhythmic drug such as sotalol hydrochloride, flecainide acetate, propafenone hydrochloride, or amiodarone hydrochloride; dronedarone may be considered in paroxysmal or persistent atrial fibrillation (see NICE guidance).
If drug treatment is required to maintain sinus rhythm (‘rhythm control’) post-cardioversion, a standard beta-blocker is used. If a standard beta-blocker is not appropriate or is ineffective what should be considered?
If drug treatment is required to maintain sinus rhythm (‘rhythm control’) post-cardioversion, a standard beta-blocker is used. If a standard beta-blocker is not appropriate or is ineffective, consider an oral anti-arrhythmic drug such as sotalol hydrochloride, flecainide acetate, propafenone hydrochloride, or amiodarone hydrochloride; dronedarone may be considered in paroxysmal or persistent atrial fibrillation (see NICE guidance).
Dronedarone may be considered in what AF?
If drug treatment is required to maintain sinus rhythm (‘rhythm control’) post-cardioversion, a standard beta-blocker is used. If a standard beta-blocker is not appropriate or is ineffective, consider an oral anti-arrhythmic drug such as sotalol hydrochloride, flecainide acetate, propafenone hydrochloride, or amiodarone hydrochloride; dronedarone may be considered in paroxysmal or persistent atrial fibrillation (see NICE guidance).
If necessary, amiodarone can be started how long before and continued for how long after electrical cardioversion to increase the success of the procedure, and to maintain sinus rhythm?
4 weeks before and for 12 months after
Flecaine acetate or propagenone hydrochloride should not be given in what circumstances?
If there is known ischaemic or structural heart disease.
In symptomatic paroxysmal atrial fibrillation, ventricular rhythm is controlled with a standard beta-blocker. Alternatively, if symptoms persist or a standard beta-blocker is not appropriate, what can be given? (5)
Alternatively, if symptoms persist or a standard beta-blocker is not appropriate, an oral anti-arrhythmic drug such as dronedarone (see NICE guidance), sotalol hydrochloride, flecainide acetate, propafenone hydrochloride, or amiodarone hydrochloride can be given.
In selected paroxysmal atrial fibrillation patients with infrequent episodes, what approach can be taken?
Sinus rhythm can be restored using the ‘pill-in-the-pocket’ approach; this involves the patient taking oral flecainde or propafenone hydrochloride to self-treat an episode of AF when it occurs.
Oral anticoagulation should be offered to patients with confirmed diagnosis of atrial fibrillation with what risk factors?
- Sinus rhythm not successfully restored within 48 hours of onset.
- high risk of recurrence of AF such as those with structural heart disease, prolonged history of AF (>12 mths), a history of failed attempts at cardioversion.
- Patients whom the risk of stroke outweighs the risk of bleeding.
Why should aspitin not be offered as monotherapy soley for stroke prevention in AF?
Aspirin is less effective than warfarin sodium at preventing emboli; the modest benefit is offset by the risk of bleeding, and aspirin should not be offered as monotherapy solely for stroke prevention in atrial fibrillation.
In what types of AF can oral anticoagulation be acheived with apixaban, dabigatran, edoxaban or rivaroxaban?
Non-valvular AF
Like atrial fibrillation, treatment options for atrial flutter involve either controlling the ventricular rate or attempting to restore and maintain sinus rhythm. However, atrial flutter generally responds less well what?
Like atrial fibrillation, treatment options for atrial flutter involve either controlling the ventricular rate or attempting to restore and maintain sinus rhythm. However, atrial flutter generally responds less well to drug treatment than atrial fibrillation.
If the duration of atrial flutter is unknown, or it has lasted for over 48 hours, cardioversion should not be attempted until the patient has been fully anticoagulated for at least __ weeks; if this is not possible, parenteral anticoagulation should be commenced and a left atrial thrombus ruled out immediately before cardioversion; oral anticoagulation should be given after cardioversion and continued for at least 4 weeks.
If the duration of atrial flutter is unknown, or it has lasted for over 48 hours, cardioversion should not be attempted until the patient has been fully anticoagulated for at least 3 weeks; if this is not possible, parenteral anticoagulation should be commenced and a left atrial thrombus ruled out immediately before cardioversion; oral anticoagulation should be given after cardioversion and continued for at least 4 weeks.